| Literature DB >> 26316866 |
Abstract
Genetics should now be part of everyday clinical epilepsy practice. Good data exist to provide empiric risks based on epilepsy syndrome diagnosis. Investigation of the molecular basis of some epilepsies is now a practical clinical task and is of clear value to the patient and family. In some cases, specific therapeutic decisions can now be made based on genetic findings, and this scenario of precision therapy is likely to increase in the coming years.Entities:
Year: 2015 PMID: 26316866 PMCID: PMC4532231 DOI: 10.5698/1535-7511-15.4.192
Source DB: PubMed Journal: Epilepsy Curr ISSN: 1535-7511 Impact factor: 7.500